- Total investments reached €6 billion in the third quarter, a significant increase from €2 billion in the same period last year.
- Total gross fund exits amounted to €3 billion, representing a 50% increase year-over-year.
- Assets under management grew by 4.7% to €134 billion, slightly above the estimated €133.71 billion.
- EQT reported that all key funds were performing on plan or above expectations.
- The company is leveraging improving capital markets to heighten exit activity, though it acknowledges risks due to geopolitical uncertainties.
- EQT is preparing for additional Private Wealth products, aiming to introduce a total of five within the next 6-12 months.
- Analyst recommendations for EQT include 6 buys, 8 holds, and 2 sells.
A look at EQT Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 2 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts from Smartkarma have provided an overview of EQT, indicating that the company shows promise in terms of resilience and momentum. With a resilience score of 4, EQT is seen as having a strong ability to withstand market challenges and maintain stable performance. Additionally, its momentum score of 4 suggests that the company is gaining traction and showing positive growth trends in the long term.
While EQT has received moderate scores of 2 in the value, dividend, and growth categories, the higher ratings in resilience and momentum hint towards a potentially positive long-term outlook for the investment firm. With its diverse investment portfolio in equity, ventures, infrastructure, and real estate properties, EQT’s global presence offers opportunities for growth and stability in the future.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
